To make evidence-informed policy and public health decisions, stakeholders, including federal, provincial and regional policy makers, practitioners and community organizations, require high-quality information and access to valid and reliable data to measure the impact of their decisions ([@R20]). In Canada, although there is a growing imperative to measure HIV health system performance ([@R10]) and strengthen existing data management and infrastructure ([@R12]), significant gaps remain with respect to comprehensive, population-level data that could guide resource allocation and healthcare delivery, including prevention, treatment and care for people living with HIV (PLWH). Despite the universality of coverage for medically necessary services delivered in hospitals or by physicians in Canada and the fact that the federal government transfers funding to the provinces and territories to support such coverage, the majority of these services are paid for directly by the provinces, and therefore, the majority of health administrative data are housed provincially, with varying degrees of completion and comprehensiveness ([@R27]). As the Council of Canadian Academies states, "in Canada ... those who need access to data must navigate a 'complex environment of heterogeneous entities,' often including numerous data custodians, privacy offices and research ethics boards, whose collective governance and operational practices fall short of constituting a well-defined and coherent system" ([@R6]).

Over the past five years, a number of research-funded initiatives focusing on different areas of health, such as the Canadian Longitudinal Study on Aging and the Canadian Partnership for Tomorrow Project, have sought to develop systems or platforms to link data collected through large cohort studies across different Canadian provinces to administrative health data ([@R7]; [@R8]). They are working to devise access protocols that respect jurisdictional requirements while supporting rigorous and effective harmonization practices ([@R9]), but these are still nascent and are not yet in a position to provide researchers with access to multi-province data. It is thus heartening to see the Canadian Institutes of Health Research (CIHR) award \$39 million over seven years to the Pan-Canadian Real-World Health Data Network ([@R23]) to create the Strategy for Patient-Oriented Research (SPOR) National Data Platform that can "receive multi-jurisdictional service requests and enable a single portal of access" to provincial and territorial health data, and "provide leadership and a forum to harmonize data access requirements and processes across jurisdictions" ([@R2], [@R3]), a sum which has recently been increased to \$81 million by the federal government ([@R4]).

In the absence of such a single portal of access, however, researchers wishing to establish cohorts in more than one province/territory that are linked with administrative health data must still work one jurisdiction at a time, which is more costly and less efficient. This paper describes how we used research funding to create linked cohorts in two provinces to address data gaps, opportunities and challenges encountered in doing so and sustainability of bolstering national capacity around the HIV health system performance by using this approach.

Cohorts as a Response for Measuring Health System Performance
=============================================================

Measurement of the HIV cascade, a framework that incorporates testing for HIV diagnosis, presentation to and engagement in care and successful treatment to reach full virologic suppression, is one example of health system performance and an urgent public health priority ([@R13]). To fully characterize the HIV cascade and implement actionable policies, it is essential to know who is accessing care, who is providing care and the extent to which care is optimized ([@R22]). However, there is no national consensus about whether administrative, clinical cohort or electronic health data sources best capture cascade data; who holds accountability regarding data integrity and validity; and who is responsible for resourcing comprehensive data collection and analysis for sustainability and monitoring/evaluation ([@R16]).

The Public Health Agency of Canada collates and reports provincial and territorial public health data on HIV-relevant variables, including age, sex, ethnicity, country of birth, geographic location, transmission risk groups and HIV viral loads ([@R21]). Although critical to the HIV cascade picture, these data may not reflect the broader health complexities and health services needs of PLWH ([@R10]). Administratively collected data, on the other hand, are limited to routinely collected health services data, with varied linkage to social and other data across jurisdictions, and these do not include important patient characteristics or health system indicators to facilitate policy and provider responses ([@R25]). This gap has led research teams in Ontario ([@R19]), British Columbia and Quebec ([@R5]; [@R11]; [@R14]) to create provincial clinical cohorts of PLWH by comprehensively linking public health, administrative and cohort data.

Until recently, comparable cohorts did not exist in Manitoba or Newfoundland and Labrador. As part of a five-year CIHR--funded program of research, "Advancing Primary Health Care for Persons Living with HIV in Canada" (LHIV), and building on our Ontario experience, new clinical cohorts of PLWH were created in Manitoba and Newfoundland and Labrador and linked to provincial administrative databases. This linkage created a repository of population-level clinical, administrative and public health data that could facilitate comparisons across provinces and contribute to a national dialogue on the HIV health system performance. In addition to cascade measures, these data can be used to assess the proportion of patients using primary or specialized healthcare services given provincial geographic disparities and to provide insight into how services are being used and how they can be optimized.

Creation of LHIV Provincial Clinical Cohorts
============================================

Recruitment for Manitoba\'s clinical cohort began in October 2013. We sought consent during clinical encounters at two Winnipeg-based sites of the Manitoba HIV Program, the primary provider of HIV care in the province. Clinical data are regularly collected manually from charts or electronic medical records. Anonymized and de-identified clinical data are linked to provincial administrative health databases housed within a division of Manitoba Health, Seniors and Active Living. Manitoba is well positioned to undertake large population-based studies given its strong infrastructure of linkable, population-based administrative health databases ([@R26]). Currently, data from 871 PLWH living in Manitoba are included in the cohort, representing the first comprehensive source of health data among PLWH in Manitoba. This cohort will facilitate more sophisticated epidemiological analyses that can inform HIV care programming and provincial policy, for example, by establishing which populations are currently underserved.

Similarly, a cohort of PLWH was developed in Newfoundland and Labrador in September 2013. Because the majority of PLWH are referred to and receive care at the St. John\'s nurse-practitioner--led HIV clinic, a clinical cohort was developed similar to the Manitoba cohort. Further, an iterative approach was used to extract variables from three different databases -- provincial laboratory data, HIV clinic data and administrative health data -- using validated algorithms ([@R18]). The extraction and compilation of these databases were approved and completed by a trusted third party, the Newfoundland and Labrador Centre for Health Information. The cohort currently includes data from 251 PLWH, including demographics, laboratory tests, hospitalization visits, physician claims, mortality, cancer and co-morbidity information, pregnancy status, smoking status, country of origin and medication use. With cohort data access, researchers in Newfoundland and Labrador are able to identify the number of PLWH in the province and how many are accessing care at the HIV clinic. Table [1](#T1){ref-type="table"} provides preliminary demographic and clinical data acquired from these cohorts.

###### 

Summary of information obtained through clinical cohorts from Manitoba and Newfoundland and Labrador[^\*^](#TFN1-1){ref-type="table-fn"}

                             Manitoba (*N* = 871) *n* (%)      Newfoundland and Labrador (*N* = 251) *n* (%)
  -------------------------- ------------------------------ -- -----------------------------------------------
  **Sex**                                                      
   Male                      620 (71.2)                        189 (75.3)
   Female                    251 (28.8)                        61 (24.3)
   Other/missing                                               1 (0.4)
  **Age at diagnosis**                                         
   \<25                      126 (14.5)                        34 (13.5)
   25--34                    308 (35.4)                        78 (31.1)
   35--44                    235 (26.9)                        55 (21.9)
   45--54                    136 (15.6)                        36 (14.3)
   ≥55                       66 (7.6)                          14 (5.7)
   Missing                   0                                 34 (13.5)
  **Ethnicity**                                                
   Caucasian                 373 (42.8)                        180 (71.7)
   Indigenous                358 (41.1)                        --
   African Caribbean Black   94 (10.8)                         13 (5.2)
   Asian                     31 (3.6)                          --
   Other/missing             15 (1.7)                          58 (23.1)

                                             Manitoba Regional Health Authorities   Newfoundland and Labrador Health Regions                       
  ------------------------------------------ -------------------------------------- ------------------------------------------ ------------------- ------------
                                             Southern                               35 (4.0)                                   Central             21 (8.4)
                                             Prairie Mountain                       33 (3.8)                                   Western             18 (7.2)
                                             Winnipeg + Churchill                   00 (80.4)                                  Eastern             202 (80.5)
                                             Interlake-Eastern                      48 (5.5)                                   Grenfell-Labrador   ≤6
                                             Northern                               33 (3.8)                                   Unknown             ≤6
                                             Unknown                                22 (2.5)                                                       
  **Primary care access**                    621 (71.3)                                                                        232 (92.4)          
  **Co-infections/co-morbidities**                                                                                                                 
   Hepatitis C                               152 (17.5)                                                                        6 (2.4)             
   Asthma/COPD                               123 (14.1)                                                                        29 (11.6)           
   Hypertension                              104 (11.9)                                                                        48 (19.1)           
   Type II diabetes                          92 (10.6)                                                                         17 (6.8)            
   Ischemic heart disease                    29 (3.3)                                                                          7 (2.8)             
   Receiving antiretroviral treatment        823 (94.5)                                                                        81 (32.3)           
   Suppressed viral load (\<200 copies/ml)   128 (14.7)                                                                        66 (26.3)           

data from June 2017

Challenges to Cohort Creation
=============================

The development of these cohorts was not without challenges. In Manitoba, some potential participants expressed apprehension regarding the kinds of data collected and how they will be used and concerns regarding confidentiality. The idea of using provincial administrative health data for research is a new concept to many individuals, and the study staff spent considerable time explaining the processes through which the study is able to link clinical and administrative data while maintaining anonymity and confidentiality. Potential participants were assured that they would never be contacted by the research team outside of the clinic setting to maintain confidentiality and that access to the master list containing study identification numbers and names was highly secured and restricted to two members of the research team. At the institutional level, it is challenging to integrate the cohort enrolment protocols into established clinic operations. In the context of an over-burdened healthcare system, it is difficult to ask busy providers to incorporate additional procedures related to research studies into their routine encounters with clients. The Manitoba LHIV study team engages regularly with providers to emphasize the benefits of the cohort for their own practice and for Manitoba HIV Program\'s ability to meet the needs of its clients. Furthermore, because enrolment protocols are clinic-based, the clinical cohort under-represents PLWH who are sub-optimally engaged in care, thereby limiting the generalizability of cohort findings.

In Newfoundland and Labrador, there are risks to confidentiality among its predominantly rural population ([@R24]), and a number of steps and ethical considerations had to be considered to ensure the cohort remained anonymous. Newfoundland and Labrador developed a data governance model that united researchers, data custodians, clinicians, patients, trainees and data experts, who met regularly to discuss any challenges and to develop mitigation strategies ([@R1]). Inconsistencies across databases (provincial laboratory, clinic and health administrative data) posed another challenge, as PLWH were not necessarily identified by all three sources. Continuous data quality is a challenge for any clinical cohort; administrators and policy makers need to adopt the latest coding standards and diagnostic systems and ensure coders and physicians are trained to use them correctly ([@R17]). Some provincial databases were transitioning to an electronic medical system during cohort development, and the data of patients whose files had not yet been transferred may have been missed. Thus, the cohort was developed to be an interactive database that is retrospectively updated bi-annually with new PLWH data.

Our processes of stakeholder engagement, cohort development, data linkage and cross-system alignment of variable and outcome definitions have been undertaken entirely using research funds, as the research questions answered by the LHIV team could not have been addressed before the creation of clinical cohorts in these two provinces and their linkage with established administrative data. Leveraging research funds was beneficial during cohort development because it provided the flexibility of using innovative approaches guided by scientific evidence, but such funding is time-limited and therefore cannot ensure the sustainability of the cohorts.

Conclusion
==========

Research funding has allowed the LHIV research team to develop clinical cohorts of PLWH in Manitoba and Newfoundland and Labrador, and it has created platforms for linking these cohorts to provincial health administrative databases. The established clinical cohorts will, for the first time, allow us to use rich individual-level clinical data to understand population-level healthcare delivery to PLWH in these provinces. One aim of the LHIV team was to compare HIV epidemics across provinces, but the unique provincial challenges experienced with respect to data collection and linkage, as well as the complexity of and time required to pool cohort data of multiple provinces into one repository, mean comparisons will have to be conducted at the aggregate level. Further, for these cohorts to be developed and maintained, a more stable and sustainable source of funding is required than research funding, which is time-limited and episodic. LHIV funding ends in 2020, and it is unclear how the linked cohorts we have established will be maintained thereafter. Without meaningful multi-stakeholder investment in data collection, linkage and analysis, system-level measures of comprehensive HIV performance measurement in Canada are unlikely in our foreseeable future ([@R15]). We urge stakeholders, including researchers, public health and stewards of administrative data at the provincial and national levels, to collaborate across silos, collect data in Canadian jurisdictions that are generally under-represented and commit to action on infrastructure such as the SPOR National Data Platform. This will facilitate rigorous harmonization across studies and will inform the direction of the evidence-based health system for the care of PLWH and other chronic conditions.
